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Abstract 31 
Elastomeric pumps can be used for the continuous administration of antimicrobials in the outpatient 32 
setting. A potentially limiting factor in their use is the stability of antimicrobials.  This study aimed to 33 
investigate under real-life conditions the temperature variations of antibiotic solutions contained in 34 
elastomeric pumps, and to examine under such conditions the stability of five antibiotics.  35 
Healthy volunteers carried the elastomeric pumps in carry pouches during their daily activities. A 36 
thermologger measured the temperatures every 15 minutes over 24 hours (h). Antibiotic concentrations 37 
were measured by high performance liquid chromatography coupled to tandem mass spectrometry.  38 
 During daytime, the temperature of solutions in the pumps increased steadily warming up to above 30°C. 39 
During the night, when the pumps were kept attached to the waist, the temperatures reached up to 33°C. 40 
The use of white carry pouches allowed to reduce excessive temperature increases. Over 7 experiments 41 
cefazolin, cefepime, piperacillin and tazobactam were found to be stable during 24h. Flucloxacillin showed 42 
a mean decrease in concentration of -11% (p = 0.001).  43 
Real-life situations can cause significant temperature rises in elastomeric pumps, thereby potentially 44 
increasing the risk of antibiotic degradation. Patients should be instructed to avoid the situations causing 45 
excessive temperature increases. Despite these temperature variations cefazolin, cefepime, piperacillin 46 
and tazobactam were found to be stable over 24 h. A moderate degradation was noticed for flucloxacillin, 47 
albeit most probably not to an extent that might impair anti-infective efficacy.  48 
Background 49 
When considering outpatient parenteral antimicrobial therapy (OPAT) for a patient, the selection of the 50 
suitable antibiotic should remain guided by the usual criteria of anti-infective therapy (ie. susceptibility of 51 
the isolated germs, severity and site of infection) rather than by the availability of some antibiotic that 52 
would just be easier to use.1,2 In that context, elastomeric pumps proved to be useful and at the OPAT 53 
Unit of the University Hospital of Lausanne, Switzerland, elastomeric pumps for continuous antimicrobial 54 
infusions are used in more than one third of patients. 3   55 
A few practical contingencies may limit the generalized use of continuous infusions with elastomeric 56 
pumps. Especially the stability of the antimicrobials in real-life conditions is poorly known. An excessive 57 
increase in temperature may accelerate drug degradation and might even yield toxic waste products.4  58 
At present, the vast majority of published antimicrobial stability data emanate from the manufacturers of 59 
elastomeric pumps. According to these sources, the maximal recommended duration of infusion is based 60 
on experiments performed under laboratory conditions, whereby antibiotic solutions are exposed to 61 
constant temperatures of -5°C, 5°C and 25°C.4 Actually, only two small studies have explored antibiotics 62 
solution stability at a higher temperature of up to 35°C.5,6  63 
The aims of the present study were to investigate the temperature changes within elastomeric pumps 64 
during daily activities of subjects, and to determine the stability of some antimicrobials frequently used 65 
in elastomeric pumps under real-life conditions.  66 
 67 
Methods 68 
The experiments exploring the temperatures of the solutions in the pumps were carried out in Lausanne, 69 
Switzerland, between July 2014 and February 2015. The external temperatures during July varied between 70 
4°C and 27°C, and during February between -1° and 12°C. Each experiment was repeated 3 times. 71 
Elastomeric pumps of the brand Easypump LT-270-24® (B. Braun Medical Inc, Melsungen, Germany) were 72 
used.  73 
The temperature of the solutions in the pumps was measured using a temperature logger (LogTag TREX-74 
8, LogTag Recorders, Auckland, New Zealand) equipped with an external temperature sensor (ST100J-15), 75 
which was inserted into the hollow cylinder forming the solid base of the Easypump®. In preliminary 76 
experiments this setup showed to measure temperatures which were very close to the real temperature 77 
of the solution in the pumps.  78 
The antimicrobial drugs and concentrations thereof tested in our study were as follows: flucloxacillin 33 79 
g/L, cefazolin 25 g/L, cefepime 12.5 g/L, piperacillin 50 g/L and tazobactam 6.25 g/L. These concentrations 80 
correspond to the following 24-h doses when infused in an elastomeric pump filled with 240 mL of solution 81 
and running at 10 mL/h: flucloxacillin 8 g, cefazolin 6 g, cefepime 3 g, piperacillin/tazobactam 13.5 g. The 82 
maximal duration of stability at room temperature (25oC) of these antibiotics diluted in normal saline have 83 
been reported as follows by the manufacturer of the elastomeric pumps: flucloxacillin: 24 h at 84 
concentrations up to 70 g/L; cefazolin: 48 h at 16.7 g/L; cefepime: 24 h at 20 g/L; piperacillin: 24 h at 80 85 
g/L; tazobactam: 24 h at 10 g/L.7 86 
The antimicrobial drugs stability experiments were carried out under the real-life conditions that would 87 
cause the smallest temperature variations as identified by above-described experiments. The volunteers 88 
were asked to collect 5 mL-aliquot samples from the elastomeric pump at the 0-, 12- and 24-h time points, 89 
and to keep these samples stored at 4°C, before bringing them for storage at -80°C at the laboratory prior 90 
to analysis. For each antimicrobial drug, the experiment was performed on 7 different occasions. 91 
Antimicrobial drug concentrations were measured by a validated method of liquid chromatography 92 
coupled to tandem mass spectrometry (LC-MS/MS) using stable isotopically-labelled Internal Standards 93 
and matrix-matched calibration samples. The log-transformed concentration results were analysed with 94 
a multilevel linear model; if their slope over time differed significantly from zero, it was transformed back 95 
and expressed as a half-life with 95% confidence interval (CI95%).   96 
 97 
Results 98 
Temperature variations over 24 h in real-life situations 99 
Firstly, we evaluated the evolution of temperature of the antibiotic solution during the night when the 100 
elastomeric pumps were carried around the subject’s waist (continuous curve) versus kept beside the 101 
head, outside of the blankets (dashed curve) (Figure 1). The mean temperatures over 24 h derived for 102 
these situations were 30.9 (SD 0.9°C) and 26.2 (SD 1.0°C), respectively. When the pumps were maintained 103 
under the blankets during the night, the temperature of solution increased by 2.6 (SD 1.4°C) over 6 h, 104 
while the temperatures decreased by 2.8 (SD 2.9°C) over 6 h when the pumps were kept outside of the 105 
blankets. 106 
Secondly, direct exposure of to sun during a summer day led to the following temperature increases:  in 107 
white carry pouches, the temperature of the solution increased by up to +5.3oC/h during the first hours 108 
of sunlight exposure, reaching a maximum of 38.8°C, while in black pouches the temperature increased 109 
by up to +8.3oC per hour, reaching 45.4°C.  110 
Thirdly, the usefulness of isothermal carry pouches was investigated. The volunteers carried 111 
simultaneously elastomeric pumps placed in a normal and in an isothermal carry pouch. The type of pouch 112 
modified neither the average temperature (26.2; SD 3.3°C versus 25.9; SD 3.0°C respectively, p=0.60), nor 113 
the number of measurements above 25°C (60% versus 56.9% respectively, p = 0.45). Only do the curves 114 
suggest that the isothermal pouch added some amount of caloric inertia to the system.  115 
 116 
Antimicrobial degradation 117 
Figure 2 shows the evolution of the antibiotic concentrations measured at T0, T12 and T24 in elastomeric 118 
pumps. Cefazolin, cefepime, piperacillin and tazobactam were found to be stable over 24h with mean 119 
degradation after 24 h of +4%, -4%, -2% and -2% respectively. Flucloxacillin however showed a mean 120 
decrease in concentration of -11% after 24h. The corresponding slope over time was significantly negative, 121 
indicating a degradation half-life of 137 h (CI95%: 93–259 h, p=0.001). On this basis, the relative loss over 122 
24 h was estimated to amount to 11% (6–16%) for flucloxacillin.  123 
Even though elastomeric pumps were supposedly filled with antibiotics at the same concentrations, 124 
significant inter-preparation variability was found in these T0 concentrations, with coefficients of variation 125 
of 6.0, 5.1, 11.6, 12.3 and 23.3% for flucloxacillin, cefazolin, cefepime, piperacillin and tazobactam, 126 
respectively. Piperacillin and tazobactam, formulated in fixed association, were strongly correlated among 127 
solutions prepared from a single drug batch (r2=0.98), suggesting that the observed variability is explained 128 
by dilution procedures or the sampling technique rather than analytical imprecision.  129 
 130 
Discussion  131 
The use of elastomeric pumps for ambulatory delivery of antimicrobials improves the autonomy and the 132 
convenience of patients during anti-infective treatments, not to mention its important impact on 133 
healthcare costs. In addition elastomeric pumps allow choosing from a larger number of antimicrobial 134 
substances for the outpatient treatment, permitting to select the most appropriate antimicrobial 135 
treatment.  136 
Among potential limitations in the use of elastomeric pumps, uncertainty about the stability of 137 
antimicrobial drugs in infusion solutions is of concern. In real-life conditions these solutions are indeed 138 
maintained over a prolonged duration (24 h) and exposed to non-negligible temperature variations.  139 
Our study confirms that during daytime the temperature of antibiotics solutions in pumps progressively 140 
increased well above 25°C, the temperature at which most stability studies are conducted. Heat provided 141 
by direct exposure to sunlight was found to cause particularly significant increase in temperature. Our 142 
experiments also show that antibiotics solutions stored in black carry pouches overheat more than those 143 
placed in white carry pouches and that isothermal carry pouches are not efficient to reduce significant 144 
temperature variations. During the night, when the pump remains around the waist in direct contact with 145 
patient’s body and kept under the blanket, the temperature may increase up to 32°C.  146 
In order to ensure adequate anti-infective activity, usual recommendations state that the antibiotic 147 
degradation at the end of the infusion period should be less than 10% from the initial concentration.1,2 148 
Our experiments performed in real-life, albeit under conservative conditions, showed that cefazolin, 149 
cefepime, piperacillin and tazobactam can be considered stable over 24 hours, while flucloxacillin showed 150 
a mean decrease in concentration of -11% after 24 h. In spite of this degradation, it is very unlikely that it 151 
could put patients at risk of insufficient antimicrobial coverage. Our confidence intervals indicate that 152 
actual degradation rates have very little chances to reach -20%.  153 
There are some limitations to these data. The determination of initial concentrations at T0 already showed 154 
some variability and deviations in the antibiotic concentrations in the pumps compared to nominal levels. 155 
As explained above, this was probably due to imprecision occurring during the preparation of 156 
antimicrobial solutions or due to the sampling technique. Furthermore this study didn’t look at the 157 
production of toxic degradation products and variations in the pH. 158 
In conclusion, our results show that in certain real life situations the temperature of antimicrobial 159 
solutions in elastomeric pumps can largely exceed the recommended temperature of 25°C, thus 160 
potentially affecting the chemical stability of the drugs. Patients should therefore be instructed to take 161 
precautions to prevent excessive temperature increases.  If appropriate precautions are taken, we finally 162 
demonstrate that under real-life conditions, no significant degradation of cefazolin, cefepime, piperacillin 163 
and tazobactam is observed. For flucloxacillin, degradation of -11% is expected over 24 h, however with 164 
questionable impact on the actual efficacy of anti-infective treatment.  165 
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  192 
Figure 1. Evolution of temperature in two elastomeric pumps worn by the same volunteer, one carried 193 
attached around the waist (continuous line) and one detached (dashed line) during night time 194 
(shadowed area).  195 
  196 
Figure 2. Degradation of antibiotics in elastomeric pumps sampled at 0, 12 and 24 h under real-197 
life conditions indicated as mean concentration and standard deviation 198 
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